Wondfo Biotech begins share repurchase program

Guangzhou Wondfo Biotech Co., Ltd. announced the commencement of its share repurchase program, approved on September 23, 2025. The company intends to use its own funds to repurchase RMB common shares for employee stock ownership plans and equity incentives, with a total investment of no less than RMB 30,000,000 and no more than RMB 60,000,000. The maximum repurchase price is RMB 34.66 per share, with the program to run for six months from the approval date.

As of September 30, 2025, Wondfo Biotech has repurchased 13,000 shares through its dedicated stock repurchase account via centralized bidding, representing 0.0028% of its total share capital.

The highest and lowest transaction prices for these repurchases were both RMB 21.21 per share, resulting in a total transaction amount of RMB 275,729.00 (excluding transaction fees).